Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,043
Award facts
- Contract value 100% obligated
- $34,042.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,042.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, was executed without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V program establishes multiple regional prime vendor contractors to provide recurring pharmaceutical and medical supply support to military healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a key provider within the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEHZM?
SPE2DU26FEHZM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DU26FEHZM worth?
The government has obligated $34,043 on SPE2DU26FEHZM.
Is contract SPE2DU26FEHZM an order under another contract?
Yes. SPE2DU26FEHZM is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZM competed?
The extent of competition for SPE2DU26FEHZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award